TFA Therapeutics, Inc.
RAJAF· OTC
Quarterly figures for TFA Therapeutics, Inc., with source filings when available.
2 quarters. Dec 31, 2022 to Dec 31, 2023. USD.
Filing lag not yet established. Fewer than two comparable filings are on file.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | — | — | |||||
TFA Therapeutics, Inc. · CIK 1885680 · Engraved from SEC EDGAR
| — |
| $315.50K |
| — |
| — |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | — | — | — | — | — | — | |